Key Financial Data Of Reporting Company

BrightPath Biotherapeutics Co., Ltd. - Filing #7722100

Concept As at
2018-06-30
2018-04-01 to
2018-06-30
2017-04-01 to
2018-03-31
As at
2018-03-31
As at
2017-06-30
2017-04-01 to
2017-06-30
Key financial data of reporting company
Business results of reporting company
Net sales
122,129,000 JPY
354,410,000 JPY
90,638,000 JPY
Ordinary profit (loss)
-399,107,000 JPY
-1,573,292,000 JPY
-262,140,000 JPY
Net assets
6,376,548,000 JPY
6,950,570,000 JPY
4,947,694,000 JPY
Total assets
6,595,415,000 JPY
7,235,902,000 JPY
5,099,490,000 JPY
Basic earnings (loss) per share
-13.94
-41.25
-7.08
Diluted earnings per share
Equity-to-asset ratio
0.957 xbrli:pure
0.953 xbrli:pure
0.964 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.